Cargando…
A Selective V(1A) Receptor Agonist, Selepressin, Is Superior to Arginine Vasopressin and to Norepinephrine in Ovine Septic Shock*
Selective vasopressin V(1A) receptor agonists may have advantages over arginine vasopressin in the treatment of septic shock. We compared the effects of selepressin, a selective V(1A) receptor agonist, arginine vasopressin, and norepinephrine on hemodynamics, organ function, and survival in an ovine...
Autores principales: | He, Xinrong, Su, Fuhong, Taccone, Fabio Silvio, Laporte, Régent, Kjølbye, Anne Louise, Zhang, Jing, Xie, Keliang, Moussa, Mouhamed Djahoum, Reinheimer, Torsten Michael, Vincent, Jean-Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684247/ https://www.ncbi.nlm.nih.gov/pubmed/26496451 http://dx.doi.org/10.1097/CCM.0000000000001380 |
Ejemplares similares
-
Selepressin and Arginine Vasopressin Do Not Display Cardiovascular Risk in Atherosclerotic Rabbit
por: Boucheix, Olivier, et al.
Publicado: (2016) -
Selepressin, a novel selective vasopressin V(1A) agonist, is an effective substitute for norepinephrine in a phase IIa randomized, placebo-controlled trial in septic shock patients
por: Russell, James A., et al.
Publicado: (2017) -
Arginine vasopressin in septic shock: supplement or substitute for norepinephrine?
por: Rehberg, Sebastian, et al.
Publicado: (2009) -
Arteriolar vasoconstrictive response: comparing the effects of arginine vasopressin and norepinephrine
por: Friesenecker, Barbara E, et al.
Publicado: (2006) -
Arginine vasopressin versus norepinephrine: will the stronger one win the race?
por: Ertmer, Christian, et al.
Publicado: (2006)